induction therapy
Showing 1 - 25 of >10,000
Lupus Nephritis, Remission, Safety Issues Trial in Nanjing (Methylprednisolone Injectable Suspension, Belimumab Injection,
Recruiting
- Lupus Nephritis
- +2 more
- Methylprednisolone Injectable Suspension
- +2 more
-
Nanjing, Jiangsu, ChinaJiong Zhang
May 8, 2023
Acute Promyelocytic Leukemia, Induction Therapy, Oral Trial in Beijing (Etoposide, Daunorubicin)
Recruiting
- Acute Promyelocytic Leukemia
- +2 more
-
Beijing, Beijing, ChinaPeking University Institute of Hematology
Apr 26, 2023
Hemophagocytic Syndrome Trial in Chongqing (cyclophosphamide, VP-16, Dexamethasone)
Recruiting
- Hemophagocytic Syndrome
- cyclophosphamide
- +3 more
-
Chongqing, ChinaThe Second affiliated Hosptial of Chongqing medical University
Jun 28, 2023
Crohn Disease Trial (selective intensive induction therapy based on ustekinumab clinical decision-making tools)
Not yet recruiting
- Crohn Disease
- selective intensive induction therapy based on ustekinumab clinical decision-making tools
- (no location specified)
May 6, 2023
Fascia, Trigger Point Pain, Myofascial, Range of Motion Trial in Madrid (Calf myofascial technique)
Completed
- Fascia
- +3 more
- Calf myofascial technique
-
Madrid, SpainEva María Martinez Jiménez
Feb 9, 2023
PD-1 Antibody, Hemophagocytic Lymphohistiocytosis, Epstein-Barr Virus Trial in Beijing (L-DEP and PD-1 antibody)
Not yet recruiting
- PD-1 Antibody
- +3 more
- L-DEP and PD-1 antibody
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Mar 8, 2023
Pediatric Induction Therapy in Kidney Transplantation
Completed
- Kidney Transplant Rejection
- Pediatric Kidney Disease
- Basiliximab Injection
- rabbit ATG
-
Guangzhou, Guangdong, China
- +4 more
Oct 15, 2023
Ulcerative Colitis Trial in Melbourne (Infliximab)
Active, not recruiting
- Ulcerative Colitis
-
Melbourne, Victoria, AustraliaAustin Health
Jun 19, 2022
Locally Advanced, NSCLC Trial in Shanghai (drug, procedure, radiation)
Recruiting
- Locally Advanced
- Non-small Cell Lung Cancer
- Serplulimab
- +5 more
-
Shanghai, ChinaShanghai Pulmonary Hospital
Mar 14, 2023
B Acute Lymphoblastic Leukemia Trial in Suzhou (Blinatumomab)
Recruiting
- B Acute Lymphoblastic Leukemia
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University, Jiangsu Ins
Nov 1, 2022
Cesarean Section Complications Trial (myofascial induction and direct scar release techniques, therapeutic ultrasound)
Not yet recruiting
- Cesarean Section Complications
- myofascial induction and direct scar release techniques
- therapeutic ultrasound
- (no location specified)
Jul 12, 2023
Esophageal Cancer, Nutrition Aspect of Cancer Trial in London (No feeding tube placed, Placement of a percutaneous feeding tube)
Not yet recruiting
- Esophageal Cancer
- Nutrition Aspect of Cancer
- No feeding tube placed
- Placement of a percutaneous feeding tube
-
London, Ontario, CanadaLondon Health Sciences Centre - Victoria Hospital
Aug 4, 2022
Acute Myeloid Leukemia Trial in Aurora (Azacitidine and Venetoclax)
Active, not recruiting
- Acute Myeloid Leukemia
- Azacitidine and Venetoclax
-
Aurora, ColoradoUniversity of Colorado Denver
Aug 1, 2022
Acute Myeloid Leukemia Trial in Kunming (Venetoclax in combination with azacitidine and CAG)
Recruiting
- Acute Myeloid Leukemia
- Venetoclax in combination with azacitidine and CAG
-
Kunming, Yunnan, China920th Hospital of Joint Logistics Support Force of People's Libe
Dec 20, 2022
Histological or Cytological Confirmed Stage ? and ?a Thymoma Trial in Shanghai (NAB-Paclitaxel plus Cisplatin, Cisplatin plus
Not yet recruiting
- Histological or Cytological Confirmed Stage Ⅲ and Ⅳa Thymoma
- NAB-Paclitaxel plus Cisplatin
- Cisplatin plus Epirubicin plus Cyclophosphamide
-
Shanghai, Shanghai, ChinaYian Zhang
Apr 17, 2023
Pancreatic Cancer Trial (Chemotherapy, Radiation)
Active, not recruiting
- Pancreatic Cancer
- Chemotherapy
- Radiation
- (no location specified)
May 30, 2022
Acute Myeloid Leukemia (AML) Trial in Leipzig (VEN+AZA-5)
Not yet recruiting
- Acute Myeloid Leukemia (AML)
-
Leipzig, GermanyUniversitätsklinikum Leipzig, Klinik und Poliklinik für Hämatolo
Apr 25, 2023
Head Neck Cancer, Larynx Trial in Lexington (Low dose fractionated radiation - 80cGy with chemo, Docetaxel and Carboplatin AUC
Active, not recruiting
- Head and Neck Cancer
- Larynx
- Low dose fractionated radiation - 80cGy with chemotherapy
- Docetaxel and Carboplatin AUC 6
-
Lexington, KentuckyUniversity of Kentucky, Markey Cancer Center
Aug 29, 2022
Head and Neck Squamous Cell Carcinoma, Radiotherapy, Immunotherapy Trial in Wuhan (induction therapy; surgery; radiotherapy)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- +3 more
- induction therapy; surgery; radiotherapy
-
Wuhan, Hubei, ChinaHubei Cancer Hospital
Jul 25, 2022
Lymphoid Leukemia, Small Lymphocytic Lymphoma, Lymphoma, Non-Hodgkin Trial in Madison (Bendamustine, Rituximab, Lenalidomide)
Completed
- Lymphoid Leukemia
- +2 more
- Bendamustine
- +2 more
-
Madison, WisconsinUniversity of Wisconsin
Jan 30, 2023
Rehabilitation Trial in Konya (High Induction Magnetic Field Therapy, Conservative Treatment)
Recruiting
- Rehabilitation
- High Induction Magnetic Field Therapy
- Conservative Treatment
-
Konya, Karatay, TurkeyKTO Karatay University
Nov 3, 2023
Generate Real World Data On Tofacitinib Induction Therapy and
Recruiting
- Ulcerative Colitis
- Stool sample collection
-
Bern, Bern (de), Switzerland
- +8 more
Jan 25, 2023
Giant Cell Arteritis Trial in Bonn (Methotrexate, Sodium chloride)
Recruiting
- Giant Cell Arteritis
- Methotrexate
- Sodium chloride
-
Bonn, GermanyMedical Clinic and Polyclinic III Internal medicine Oncology, He
Dec 16, 2022